Successful development of novel anti-atherosclerosis therapies is hampered by the lack of imaging biomarkers for their evaluation. In their article, Lindsay and Choudhury compare and contrast the ability of current atherosclerosis imaging modalities to predict clinical outcomes and discuss the potential of emerging technologies to aid anti-atherosclerosis drug development by quantifying changes in biological function at the level of the atherosclerotic plaque.
- Alistair C. Lindsay
- Robin P. Choudhury
